Paola Grandi
GlaxoSmithKline (Germany)(DE)
Publications by Year
Research Areas
PARP inhibition in cancer therapy, Protein Degradation and Inhibitors, Multiple Myeloma Research and Treatments, Biosimilars and Bioanalytical Methods, Ubiquitin and proteasome pathways
Most-Cited Works
- → Functional organization of the yeast proteome by systematic analysis of protein complexes(2002)4,765 cited
- → Proteome survey reveals modularity of the yeast cell machinery(2006)2,561 cited
- → Catalytic in vivo protein knockdown by small-molecule PROTACs(2015)1,271 cited
- → Chemoproteomics profiling of HDAC inhibitors reveals selective targeting of HDAC complexes(2011)661 cited
- → 90S Pre-Ribosomes Include the 35S Pre-rRNA, the U3 snoRNP, and 40S Subunit Processing Factors but Predominantly Lack 60S Synthesis Factors(2002)451 cited
- → Selective targeting of BD1 and BD2 of the BET proteins in cancer and immunoinflammation(2020)416 cited
- → CAR-Engineered NK Cells Targeting Wild-Type EGFR and EGFRvIII Enhance Killing of Glioblastoma and Patient-Derived Glioblastoma Stem Cells(2015)330 cited
- → A CAF-1–PCNA-Mediated Chromatin Assembly Pathway Triggered by Sensing DNA Damage(2000)329 cited
- → Identification of a 60S Preribosomal Particle that Is Closely Linked to Nuclear Export(2001)299 cited
- → Discovery of a first-in-class reversible DNMT1-selective inhibitor with improved tolerability and efficacy in acute myeloid leukemia(2021)262 cited